Boston, MA–(ENEWSPF)–March 6, 2014. More than 230,000 men will be diagnosed with prostate cancerthis year in the United States, but determining their course of treatment remains a source of considerable debate. A new study by researchers from Uppsala University Hospital, Sweden, Harvard School of Public Health (HSPH) and colleagues—which draws from one of the few randomized trials conducted to directly address this issue—finds a substantial long-term reduction in mortality for men with localized…
